Literature DB >> 8016212

Photophysical and photosensitizing properties of benzoporphyrin derivative monoacid ring A (BPD-MA).

B Aveline1, T Hasan, R W Redmond.   

Abstract

The photophysical properties of benzoporphyrin derivative monoacid ring A (BPD-MA), a second-generation photosensitizer currently in phase II clinical trials, were investigated in homogeneous solution. Absorption, fluorescence, triplet-state, singlet oxygen (O2 (1 delta g)) sensitization studies and photobleaching experiments are reported. The ground state of this chlorin-type molecule shows a strong absorbance in the red (lambda approximately 688 nm, epsilon approximately 33,000 M-1 cm-1 in organic solvents). For the singlet excited state the following data were determined in methanol: energy level, Es = 42.1 kcal mol-1, lifetime, tau f = 5.2 ns and fluorescence quantum yield, phi f = 0.05 in air-saturated solution. The triplet state of BPD-MA has a lifetime, tau T > or = 25 microseconds, an energy level, ET = 26.9 kcal mol-1 and the molar absorption coefficient is epsilon T = 26,650 M-1 cm-1 at 720 nm. A dramatic effect of oxygen on the fluorescence (phi f) and intersystem crossing (phi T) quantum yields has been observed. The BPD-MA presents rather high triplet (phi T = 0.68 under N2-saturated conditions) and singlet oxygen (phi delta = 0.78) quantum yields. On the other hand, the presence of oxygen does not significantly modify the photobleaching of this photostable compound, the photodegradation quantum yield (phi Pb) of which was found to be on the order of 5 x 10(-5) in organic solvents.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8016212     DOI: 10.1111/j.1751-1097.1994.tb05042.x

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  39 in total

Review 1.  Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapy.

Authors:  G Soubrane; N M Bressler
Journal:  Br J Ophthalmol       Date:  2001-04       Impact factor: 4.638

2.  Ascorbate enhances the toxicity of the photodynamic action of Verteporfin in HL-60 cells.

Authors:  Galina G Kramarenko; Werner W Wilke; Disha Dayal; Garry R Buettner; Freya Q Schafer
Journal:  Free Radic Biol Med       Date:  2006-01-19       Impact factor: 7.376

Review 3.  BODIPY dyes in photodynamic therapy.

Authors:  Anyanee Kamkaew; Siang Hui Lim; Hong Boon Lee; Lik Voon Kiew; Lip Yong Chung; Kevin Burgess
Journal:  Chem Soc Rev       Date:  2012-09-26       Impact factor: 54.564

4.  Singlet oxygen dosimetry modeling for photodynamic therapy.

Authors:  Xing Liang; Ken Kang-Hsin Wang; Timothy C Zhu
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2012-02-13

5.  Stromal interactions as regulators of tumor growth and therapeutic response: A potential target for photodynamic therapy?

Authors:  Jonathan P Celli
Journal:  Isr J Chem       Date:  2012-07-24       Impact factor: 3.333

6.  Enhanced antitumor effects of BPD-MA-mediated photodynamic therapy combined with adriamycin on breast cancer in mice.

Authors:  Zhong-sheng Tong; Pei-tian Miao; Ting-ting Liu; Yong-sheng Jia; Xiao-dong Liu
Journal:  Acta Pharmacol Sin       Date:  2012-07-30       Impact factor: 6.150

7.  [Photodynamic therapy with verteporfin for uveal melanoma].

Authors:  J Wachtlin; N E Bechrakis; M H Foerster
Journal:  Ophthalmologe       Date:  2005-03       Impact factor: 1.059

Review 8.  Spotlight on verteporfin in subfoveal choroidal neovascularisation.

Authors:  Susan J Keam; Lesley J Scott; Monique P Curran
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

9.  PDT dose parameters impact tumoricidal durability and cell death pathways in a 3D ovarian cancer model.

Authors:  Imran Rizvi; Sriram Anbil; Nermina Alagic; Jonathan Celli; Jonathan P Celli; Lei Zak Zheng; Akilan Palanisami; Michael D Glidden; Brian W Pogue; Tayyaba Hasan
Journal:  Photochem Photobiol       Date:  2013-04-04       Impact factor: 3.421

10.  In vivo high-resolution fluorescence microendoscopy for ovarian cancer detection and treatment monitoring.

Authors:  W Zhong; J P Celli; I Rizvi; Z Mai; B Q Spring; S H Yun; T Hasan
Journal:  Br J Cancer       Date:  2009-11-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.